Advertisement
Screener

Citius Oncology, Inc. (CTOR) Long-term Purchase Commitment, Amount

Citius Oncology, Inc. Long-term Purchase Commitment, Amount

Citius Oncology, Inc. (CTOR) reported Long-term Purchase Commitment, Amount of $17.10 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Commitment and Contingencies

us-gaap:LongTermPurchaseCommitmentAmount · last filed 2026-08-14

  • Citius Oncology, Inc. long-term purchase commitment, amount for the quarter ending 2026-06-30 was $15.90M.
  • Citius Oncology, Inc. long-term purchase commitment, amount for the quarter ending 2026-03-31 was -$15.00M.
  • Citius Oncology, Inc. long-term purchase commitment, amount for the quarter ending 2025-12-31 was $16.20M, a 6.36% decline year-over-year.
  • Citius Oncology, Inc. long-term purchase commitment, amount for the quarter ending 2025-03-31 was $0.00.
Period endLong-term Purchase Commitment, Amount 3 monthLong-term Purchase Commitment, Amount 6 monthLong-term Purchase Commitment, Amount 9 month
2026-06-30$15.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14
$900.00K
derived: sum of 2 quarters · filed 2026-08-14
$17.10M
10-Q · filed 2026-08-14
2026-03-31-$15.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15
$1.20M
10-Q · filed 2026-05-15
2025-12-31$16.20M
10-Q · filed 2026-02-13
2025-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14
$17.30M
10-Q · filed 2025-05-14
2024-12-31$17.30M
10-Q · filed 2025-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anixa Biosciences Inc (ANIX)United States$0.096B
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
ProMIS Neurosciences Inc. (PMN)$0.102B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Equillium, Inc. (EQ)United States$0.109B-11.27